Information  X 
Enter a valid email address

Abzena PLC Ord GBP0.002 (ABZA)

Date Time Source Announcement
19 Jun 2018 12:28 pm
RNS
Annual Report and Accounts
14 Jun 2018 7:00 am
RNS
Funding update
04 Jun 2018 7:00 am
RNS
Final Results
29 May 2018 9:00 am
RNS
Notice of full year results
16 Apr 2018 7:25 am
RNS
Pre-Close Period Trading Update FY2018
09 Apr 2018 8:25 am
RNS
Termination of licence agreement
29 Mar 2018 5:34 pm
RNS
Issue of Ordinary Shares
05 Mar 2018 7:00 am
RNS
PacificGMP Stanford Settlement
23 Feb 2018 7:15 am
RNS
Hardman & Co Research: Investing for growth
05 Jan 2018 7:00 am
RNS
Business update on US and UK facilities
03 Jan 2018 6:12 pm
RNS
Block Listing Update
12 Dec 2017 7:00 am
RNS
Half year results: Growth strategy progressing
11 Dec 2017 7:00 am
RNS
Abzena secures ADC manufacturing services contract
21 Nov 2017 9:51 am
RNS
Notice of half year results
08 Nov 2017 2:28 pm
RNS
TR-1: Notification of major holdings
24 Oct 2017 4:15 pm
RNS
Exercise of options
27 Sep 2017 7:15 am
RNS
Hardman Research: AGM statement fully discounted
19 Sep 2017 2:25 pm
RNS
TR-1: Notification of Major Holdings
  7:00 am
RNS
Appointment of Non-Executive Director
18 Sep 2017 5:41 pm
RNS
TR-1: Notification of Major Holdings
14 Sep 2017 12:46 pm
RNS
Result of AGM
  7:00 am
RNS
Trading Update
31 Aug 2017 12:15 pm
RNS
Hardman Resrch: Accelerating towards profitability
29 Aug 2017 2:59 pm
RNS
TR-1: Notification of major holdings
  7:00 am
RNS
Notification of claim
21 Aug 2017 1:44 pm
RNS
Holding(s) in Company
28 Jul 2017 12:27 pm
RNS
Notice of AGM
18 Jul 2017 7:00 am
RNS
Abzena and Telix sign licence agreement
11 Jul 2017 7:00 am
RNS
Abzena and OBI Pharma sign licence agreement
04 Jul 2017 11:24 am
RNS
Exercise of Options
03 Jul 2017 6:11 pm
RNS
Block Listing Update
30 Jun 2017 5:19 pm
RNS
TR-1: Notification of Major Interest in Shares
19 Jun 2017 5:18 pm
RNS
Annual Report and Accounts
13 Jun 2017 7:00 am
RNS
Final Results
26 May 2017 5:24 pm
RNS
TR-1: Notification of Major Interest in Shares
24 May 2017 7:11 am
RNS
Abzena notes True North Therapeutics acquisition
16 May 2017 7:00 am
RNS
Notice of Full Year Results
03 May 2017 7:15 am
RNS
Hardman: Acceleration towards profitability
27 Apr 2017 11:09 am
RNS
TR-1: Notification of Major Interest in Shares
21 Apr 2017 11:21 am
RNS
Innovations invests �2.9m in Abzena placing
  11:21 am
RNS
Innovations invests �2.9m in Abzena placing
  11:20 am
RNS
Result of General Meeting
11 Apr 2017 3:06 pm
RNS
Director/PDMR Shareholding
07 Apr 2017 1:36 pm
RNS
Grant of options
05 Apr 2017 3:45 pm
RNS
Result of bookbuild
  7:00 am
RNS
Proposed Placing of �25m
06 Mar 2017 7:00 am
RNS
'Abzena inside' product enters Phase II trial
03 Mar 2017 7:00 am
RNS
Partner Halozyme to present poster at AACR
01 Mar 2017 7:00 am
RNS
MRC grant awarded to collaboration group
21 Feb 2017 7:01 am
RNS
Antibody manufacturing development agreement
  7:00 am
RNS
Trading and business update
06 Feb 2017 10:55 am
RNS
Total Voting Rights
31 Jan 2017 12:53 pm
RNS
Hardman Research: ThioBridge deal update
24 Jan 2017 7:00 am
RNS
Issue of Equity
20 Jan 2017 7:00 am
RNS
ThioBridge license agreement
09 Jan 2017 9:37 am
RNS
Blocklisting update
22 Dec 2016 7:00 am
RNS
Licence agreement
13 Dec 2016 7:15 am
RNS
Hardman Research: Opening new doors
30 Nov 2016 7:00 am
RNS
Half year results
23 Nov 2016 8:09 am
RNS
'Abzena inside' product study data to be presented
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t